FDA recommends warning on Tamiflu label
15th Nov 2006, 05:02 GMT
US health authorities have recommended adding a new warning to the label of Roche's influenza drug Tamiflu after reports of psychiatric side effects from patients taking the drug.
FDA recommends warning on Tamiflu label related news:
- FDA Recommends Warning on Tamiflu Label — RedOrbit News - Health
- FDA Suggests New Tamiflu Warning — WSJ.com: What's News US
- FDA Posts New Tamiflu Warning — WebMD Health Headlines
- FDA wants warning for Tamiflu drug label — floridatoday.com - Local News
- Tamiflu label gets 'abnormal behavior' warning — baltimoresun.com - nation/world
- FDA adds 'abnormal behavior' warning for Tamiflu — azcentral.com | business
- FDA adds 'abnormal behavior' warning for Tamiflu label — CNN.com Recently Published/Updated
- FDA proposes "abnormal behavior" warning for Tamiflu label — WISTV - Health
- Warning of psychiatric problems with Tamiflu. — Environmental Health News
- FDA proposes 'abnormal behavior' warning for Tamiflu label — Athens Banner Herald:News
Latest news from Pharmaceutical Business Review Latest News:
- Celesio revenues, profits up
- Amgen arthritis drug shows sustained safety and efficacy
- Study supports cardiovascular safety of naproxen
- Cangene chickenpox drug granted orphan status
- Reata brain cancer therapy shows strong activity
- Novartis diabetes drug faces three month delay
- Favrille drug fails secondary goal
- Neurogen commences human testing of obesity drug
- Aeterna prostate cancer drug shows promise
- Isis says new drug effective against cholesterol